Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 15,530 |
| Other current assets | 0 | 0 | 190 |
| TOTAL | $0 | $0 | $15,720 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 3,090 |
| Other Non-Current Assets | 0 | 0 | 340 |
| TOTAL | $N/A | $N/A | $3,430 |
| Total Assets | $0 | $0 | $18,570 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 630 |
| Accrued Expenses | 0 | 0 | 440 |
| Other current liabilities | 0 | 0 | 1,170 |
| TOTAL | $0 | $0 | $2,240 |
| Non-Current Liabilities | |||
| Long Term Debt | 0 | 0 | 9,930 |
| Other Non-Current Liabilities | 0 | 0 | 280 |
| TOTAL | $N/A | $N/A | $10,790 |
| Total Liabilities | $0 | $0 | $13,040 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 4 |
| Retained earnings | 0 | 0 | -28,340 |
| Other shareholders' equity | 0 | 0 | 33,856 |
| TOTAL | $0 | $0 | $5,520 |
| Total Liabilities And Equity | $0 | $0 | $18,560 |